ShapeShapeauthorShapecrossShapeShapeShapeGrouphamburgerhomeGroupmagnifyShapeShapeShaperssShape

Sponsor message

As a pioneer in the aquaculture industry,
INVE has always been about enabling growth

Acquisition of Huvepharma Cleared by EC

by the Fish Site Editor
15 November 2010, at 12:00am

EU - The European Commission (EC) has cleared the acquisition of Huvepharma by Citigroup.

The EC has cleared the acquisition of joint control over Bulgarian Huvepharma by Citigroup Venture Capital International Investment G.P. Limited (of Jersey) and Advance Properties, a Bulgarian investment company.

Huvepharma is predominantly active in animal health and nutrition markets, but also manufactures active pharmaceutical ingredients (APIs) for human health products.

The transaction does not meet the turnover thresholds of the Merger Regulation but would have required notification in more than three Member States. The parties therefore requested a referral of the case to the Commission pursuant to Article 4(5) of the Merger Regulation. Since none of the Member States concerned objected to the referral, the transaction is deemed to have an EU dimension and has been notified to the Commission. The parties' activities do not overlap, and the vertical effects between Huvepharma's business in some API markets and the activities of Citgroup fund companies in certain pharmaceutical markets downstream are extremely limited.

Consequently, the Commission has granted clearance to the transaction.

the Fish Site Editor

Sponsor message

The growth story of Nireus, Greece

Like all Mediterranean producers, Nireus has a strong need to market their product as fresh, affordable and high quality fish, with traceability as an important asset. Building a stable future for the company on both technical and business knowledge, Nireus realizes that a healthy economy in aquaculture can only be built on healthy fish.

Discover more growth stories